AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2018
Nov 8, 2018
34931_dirs_2018-11-08_c4170820-c8a8-41f8-aa94-e00312930af3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2018-11-07
Reporting Person: Schwalm Cynthia (Director)